CD8A and neoplasm: However, these recurrent biomarkers seemed to be somewhat divergent for high infiltration on the one hand versus intermediate/low infiltration on the other hand, for all five infiltrate measurements (sTILs; CD3 or CD8 in whole tumor; CD3 or CD8 in invasive front).